Motilal Oswal recommended Neutral rating on Info Edge (India) with a target price of Rs 4020 in its research report dated November 15, 2022.
Posts tagged MC
Neutral Info Edge (India); target of Rs 4020: Motilal Oswal (25-11-2022)
Motilal Oswal recommended Neutral rating on Info Edge (India) with a target price of Rs 4020 in its research report dated November 15, 2022.
Neutral Bata India; target of Rs 1900: Motilal Oswal (25-11-2022)
Motilal Oswal recommended Neutral rating on Bata India with a target price of Rs 1900 in its research report dated November 14, 2022.
Neutral Bata India; target of Rs 1900: Motilal Oswal (25-11-2022)
Motilal Oswal recommended Neutral rating on Bata India with a target price of Rs 1900 in its research report dated November 14, 2022.
Neutral NMDC; target of Rs 124: Motilal Oswal (25-11-2022)
Motilal Oswal recommended Neutral rating on NMDC with a target price of Rs 124 in its research report dated November 14, 2022.
Neutral NMDC; target of Rs 124: Motilal Oswal (25-11-2022)
Motilal Oswal recommended Neutral rating on NMDC with a target price of Rs 124 in its research report dated November 14, 2022.
Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal (25-11-2022)
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated November 14, 2022.
Neutral Glenmark Pharma; target of Rs 420: Motilal Oswal (25-11-2022)
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 420 in its research report dated November 14, 2022.
Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal (25-11-2022)
Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated November 14, 2022.
Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal (25-11-2022)
Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated November 14, 2022.